TY - JOUR T1 - Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study JF - Lancet Infect Dis Y1 - 2017 A1 - Deterding, K. A1 - Spinner, CD A1 - Schott, E A1 - et, al VL - 17 SP - 215-222 IS - 2 ER -